D
Pacific Biosciences of California, Inc. PACB
$1.14 -$0.03-2.56% NASDAQ
Recommendation
Prev Close
$1.14
Volume
108,589
Avg Vol (90D)
10,244,078
Market Cap
$339.55M
Dividend & Yield
--
52-Week Range
$1.08 - $2.72
P/E (TTM)
--
EPS (TTM)
-$1.14
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know
4/23/2025 - Zacks Investment Research
Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa
4/22/2025 - Globe Newswire
Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks
4/18/2025 - StockStory Articles
Selling Pacific Biosciences of California Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders
4/17/2025 - Simply Wall St
Canaccord Genuity Group Reaffirms "Buy" Rating for Pacific Biosciences of California (NASDAQ:PACB)
4/11/2025 - Ticker Report
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know
4/9/2025 - StockStory Articles
Simply Good Foods, Pacific Biosciences of California, Kura Sushi, Delta Air Lines And Other Big Stocks Moving Higher On Wednesday
4/9/2025 - Benzinga
Pacific Biosciences of California jumps 22% after prelim Q1 results, guides FY
4/9/2025 - Seeking Alpha - Healthcare
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
4/9/2025 - Globe Newswire
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks
4/9/2025 - StockStory Articles
PacBio Grants Equity Incentive Award to New Employee
4/4/2025 - Globe Newswire
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Short Interest Down 13.8% in March
4/4/2025 - MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Bought by Edmond DE Rothschild Holding S.A.
4/1/2025 - MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Purchased by Edmond DE Rothschild Holding S.A.
3/31/2025 - Ticker Report
Jim Gibson to join PacBio as Chief Financial Officer
3/27/2025 - Globe Newswire
Scotiabank Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $2.00
3/26/2025 - MarketBeat
Jackson Square Partners LLC Cuts Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
3/25/2025 - Ticker Report
Down 83%! This FTSE 250 firm could now be a stock market takeover target
3/25/2025 - The Motley Fool UK
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors
3/20/2025 - Zacks Investment Research
Here's Why You Should Retain PacBio Stock in Your Portfolio Now
3/20/2025 - Zacks Investment Research
Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations
3/19/2025 - Simply Wall St
Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading?
3/18/2025 - Insider Monkey
10 Most Volatile Stocks Under $3 For Day Trading
3/18/2025 - Insider Monkey
Nikko Asset Management Americas Inc. Lowers Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
3/18/2025 - MarketBeat
Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes
3/17/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$154.01M
EBITDA (TTM)
-$249.28M
EBIT (TTM)
-$290.46M
Net Income (TTM)
-$309.85M
Balance Sheet
Total Assets (Q)
$1.26B
Total Debt (Q)
$672.43M
Total Liabilities (Q)
$753.85M
Book Value Per Share (Q)
$1.72
Cash Flow
Cash from Operations (TTM)
-$206.06M
Cash from Investing (TTM)
$124.00M
Cash from Financing (TTM)
-$42.99M
Net Change in Cash (TTM)
-$125.04M
Filings
Filing Date
Monday, March 17, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.94
7-Day Total Return
-10.24%
30-Day Total Return
-5.00%
60-Day Total Return
-26.92%
90-Day Total Return
-44.25%
Year to Date Total Return
-36.67%
1-Year Total Return
-17.39%
2-Year Total Return
-88.83%
3-Year Total Return
-84.14%
5-Year Total Return
-65.97%
52-week Low
Mar 31, 2025 - $1.08
52-week High
Nov 07, 2024 - $2.72
Valuation
Market Cap
$339.55M - Small Cap
Enterprise Value
$622.05M
Price/Sales (TTM)
2.27
Price/Book (Q)
0.66
Dividends and Shares
Shares Outstanding
306.89M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.pacb.com
Phone Number
650 521 8000
Address
1305 O’Brien Drive
Menlo Park, CA 94025
Country
United States
Year Founded
2000
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable... more
NASDAQ 04/24/2025 4:00PM Eastern Quotes delayed